MDM2 and gastric cancer: Marked downregulation of JUN, PIK3R1, and MDM2 and upregulation of CDKN2A (P19ARF) were observed in this pathway (Figure 2D and Table S2), which might have decreased proliferation and invasion in GC.24, 25